Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 08:00 source : Www.biospace.com save search
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
Published: 2024-04-08 (Crawled : 08:00) - biospace.com/
ANPCF | News | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | News | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
her2 assay
European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Published: 2024-04-03 (Crawled : 08:00) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.08%
H: 0.3%
C: -0.99%
reblozyl anemia approval treatment
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.18%
H: 0.34%
C: -0.22%
breast her2 license cancer application negative
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
STVN | $27.22 2.56% 0.11% 230K
|
|
| O: -0.74%
H: 11.67%
C: 10.36%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.13%
H: 0.36%
C: -1.68%
group offering
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K
|
n/a
|
| O: -3.07%
H: 18.31%
C: 12.54%
ETON | $3.295 1.39% 1.37% 23K
|
Health Technology
|
| O: 6.08%
H: 5.73%
C: 3.13%
license pharmaceuticals golike therapeutics agreement
Angle PLC Announces Parsortix at European Breast Cancer Conference
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
ANPCF | News | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | News | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
conference breast cancer
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
acquisition clearance novartis
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
BPTS | $9.3 -5.3% -5.59% 9.4K
|
Manufacturing
|
| O: -8.72%
H: 13.47%
C: 6.08%
treatment
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: 1.12%
H: 0.0%
C: 0.0%
BNPQY | News | $35.58 -2.68% 97K
|
Finance and Insurance
|
| O: 0.81%
H: 0.24%
C: -0.47%
business
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.425 -7.02% 2.7K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published: 2024-03-05 (Crawled : 08:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
lung drug cancer treatment application therapeutics
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - March 01, 2024
Published: 2024-03-01 (Crawled : 08:00) - biospace.com/
ACET | News | $2.1 5.0% 4.76% 1.1M
|
Health Technology
|
| O: 0.43%
H: 2.12%
C: 1.69%
nasdaq grant
AbCellera to Present at Upcoming Investor Conferences in March 2024
Published: 2024-02-23 (Crawled : 08:00) - biospace.com/
ABCL | $3.985 -0.62% -0.63% 1.6M
|
|
| O: -1.21%
H: 0.0%
C: 0.0%
Sana Biotechnology Announces Pricing of Upsized Public Offering - February 08, 2024
Published: 2024-02-08 (Crawled : 08:00) - biospace.com/
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 4.26%
H: 7.7%
C: -3.14%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.37%
H: 0.64%
C: -0.04%
offering
Evotec SE: Invitation to Conference Call - Jan 22, 2024
Published: 2024-01-22 (Crawled : 08:00) - biospace.com/
EVO | $7.69 4.48% 4.29% 34K
|
Manufacturing
|
| O: 2.11%
H: 4.69%
C: 3.88%
conference
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results
Published: 2024-01-08 (Crawled : 08:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.81%
H: 3.68%
C: 3.31%
results
SELLAS Life Sciences Announces Proposed Public Offering - Jan 04, 2024
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SLS | $1.615 4.87% 4.64% 2M
|
Health Technology
|
| O: -31.99%
H: 1.66%
C: -5.55%
life offering sciences
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.425 -7.02% 2.7K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
fda pharma program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.425 -7.02% 2.7K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Syndax Announces Pricing of $200 Million Public Offering of Common Stock - December 15, 2023
Published: 2023-12-15 (Crawled : 08:00) - biospace.com/
SNDX | $20.95 -0.05% -0.05% 870K
|
Health Technology
|
| O: 1.71%
H: 3.36%
C: 2.72%
offering
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.